Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells

Tools
- Tools
+ Tools

Wurie, Haja R., Buckett, L., Zammit, Victor A. and UNSPECIFIED. (2011) Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells. Journal of Biological Chemistry, Vol.286 (No.42). pp. 36238-36247. ISSN 0021-9258

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1074/jbc.M111.251900

Abstract

Triacylglycerol (TAG) synthesis and secretion are important functions of the liver which have major impacts on health, as over-accumulation of TAG within the liver (steatosis) or hypersecretion of TAG within very-low-density lipoproteins (VLDL) both have deleterious metabolic consequences. Two diacylglycerol acyltransferases (DGATs 1 and 2) can catalyse the final step in the synthesis of TAG from diacylglycerol (DAG) which has been suggested to play an important role in the transfer of the glyceride moiety across the endoplasmic reticular membrane for (re)synthesis of TAG on the lumenal aspect of the endoplasmic reticular (ER) membrane [Owen, M., Corstorphine, C.G., and V.A. Zammit (1997) Biochem. J. 323, 17-21 ]. Recent topographical studies suggested that the oligomeric enzyme DGAT1 is exclusively lumen-facing (latent) in the ER membrane. By contrast, in the present study, using two specific inhibitors of human DGAT1, we present evidence that DGAT1 has a dual topology within the ER of HepG2 cells, with approximately equal DGAT1 activities exposed on the cytosolic and lumenal aspects of the ER membrane. This was confirmed by the observation of the loss of both overt (partial) and latent (total) DGAT activity in microsomes prepared from livers of Dgat1 -/- mice. Conformational differences between DGAT1 molecules having the different topologies were indicated by the markedly different sensitivities of the overt DGAT1 to one of the inhibitors. These data suggest that DGAT1 belongs to the family of oligomeric membrane proteins that adopt a dual membrane topology.

Item Type: Journal Article
Subjects: Q Science > QH Natural history > QH301 Biology
Q Science > QR Microbiology
R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Diglycerides, Acyltransferases, Insulin resistance, Endoplasmic reticulum
Journal or Publication Title: Journal of Biological Chemistry
Publisher: The American Society for Biochemistry and Molecular Biology
ISSN: 0021-9258
Date: 21 October 2011
Volume: Vol.286
Number: No.42
Page Range: pp. 36238-36247
Identification Number: 10.1074/jbc.M111.251900
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Biotechnology and Biological Sciences Research Council (Great Britain) (BBSRC), AstraZeneca (Firm)
References: 1. Gotto, A. M., Jr. (1998) Am. J. Cardiol. 82, 22Q–25Q 2. Zammit, V. A., Waterman, I. J., Topping, D., and McKay, G. (2001) J. Nutr. 131, 2074–2077 3. Erion, D. M., and Shulman, G. I. (2010) Nat. Med. 16, 400–402 4. Cases, S., Smith, S. J., Zheng, Y. W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C., Welch, C. B., Lusis, A. J., Erickson, S. K., and Farese, R. V., Jr. (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 13018–13023 5. Cases, S., Stone, S. J., Zhou, P., Yen, E., Tow, B., Lardizabal, K. D., Voelker, T., and Farese, R. V., Jr. (2001) J. Biol. Chem. 276, 38870–38876 6. Zammit, V. A., Buckett, L. K., Turnbull, A. V., Wure, H., and Proven, A. (2008) Pharmacol. Ther. 118, 295–302 7. Olofsson, S. O., Asp, L., and Bore´n, J. (1999) Curr. Opin. Lipidol. 10, 341–346 8. Lankester, D., Brown, A., and Zammit, V. (1998) J. Lipid Res. 39, 1889–1895 9. Owen, M. R., Corstorphine, C. C., and Zammit, V. A. (1997) Biochem. J. 323, 17–21 10. Gouffi, K., Ge´rard, F., Santini, C. L., and Wu, L. F. (2004) J. Biol. Chem. 279, 11608–11615 11. Waterman, I. J., Price, N. T., and Zammit, V. A. (2002) J. Lipid Res. 43, 1555–1562 12. Waterman, I. J., and Zammit, V. A. (2002) Diabetes 51, 1708–1713 13. Yang, L. Y., Kuksis, A., Myher, J. J., and Steiner, G. (1995) J. Lipid Res. 36, 125–136 14. Broadway, N., Pease, R., and Saggerson, E. (1999) in Current Views of Fatty acid Oxidation and Ketogenesis: From Organelles to Point Mutations (Quant, P., and Eaton, S., eds) pp. 59–68, Luwer Academic/Plenum Publishers, New York 15. Broadway, N. M., and Saggerson, E. D. (1995) Biochem. J. 310, 989–995 16. Abo-Hashema, K. A., Cake, M. H., Power, G. W., and Clarke, D. (1999) J. Biol. Chem. 274, 35577–35582 17. Yamazaki, T., Sasaki, E., Kakinuma, C., Yano, T., Miura, S., and Ezaki, O. (2005) J. Biol. Chem. 280, 21506–21514 18. McFie, P. J., Stone, S. L., Banman, S. L., and Stone, S. J. (2010) J. Biol. Chem. 285, 37377–37387 19. Stone, S. J., Levin, M. C., and Farese, R. V., Jr. (2006) J. Biol. Chem. 281, 40273–40282 20. Kuerschner, L., Moessinger, C., and Thiele, C. (2008) Traffic 9, 338–352 21. McFie, P. J., Banman, S. L., Kary, S., and Stone, S. J. (2011) J. Biol. Chem. 286, 28235–28246 22. Herker, E., Harris, C., Hernandez, C., Carpentier, A., Kaehlcke, K., Rosenberg, A. R., Farese, R. V., Jr., and Ott, M. (2010) Nat. Med. 16, 1295–1298 23. Adeli, K. (1994) J. Biol. Chem. 269, 9166–9175 24. Bell, R. M., Ballas, L. M., and Coleman, R. A. (1981) J. Lipid Res. 22, 391–403 25. Boon, M. R., and Zammit, V. A. (1988) Biochem. J. 249, 645–652 26. Owen, M., and Zammit, V. A. (1997) Biochem. Soc. Trans. 25, 21S 27. Kolbusz, M. A., ter Horst, R., Slotboom, D. J., and Lolkema, J. S. (2010) J. Mol. Biol. 402, 127–138 28. Hinkle, P. M., and Sebag, J. A. (2009) Mol. Cell. Endocrinol. 300, 25–31 29. Levy, D. (1996) Essays Biochem. 31, 49–60 30. Rapp, M., Granseth, E., Seppa¨la¨, S., and von Heijne, G. (2006) Nat. Struct. Mol. Biol. 13, 112–116 31. Lolkema, J. S., Dobrowolski, A., and Slotboom, D. J. (2008) J. Mol. Biol. 378, 596–606 32. Sebag, J. A., and Hinkle, P. M. (2009) J. Biol. Chem. 284, 610–618 33. Chen, Y. J., Pornillos, O., Lieu, S., Ma, C., Chen, A. P., and Chang, G. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 18999–19004
URI: http://wrap.warwick.ac.uk/id/eprint/39720

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us